U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. FDA granted granted marketing authorization for the Cue COVID-19 Molecular Test. The…
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization announced it had assigned simple, easy to say and remember…
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
U.S. FDA approved Paxlovid, first oral antiviral for treatment of COVID-19 in adults
On May 25, 2023, the U.S. FDA approved approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets,…
Large study provided scientists with deeper insight into long COVID symptoms
On May 25, 2023, the National Institutes of Health announced Initial findings from a study of nearly 10,000…
Study found COVID-19 mRNA booster vaccinations in early pregnancy did not increase miscarriage risk
On May 19, 2023, HealthPartners Institute researchers have published new data in JAMA Network Open that shows monovalent…
Obstructive sleep apnea associated with increased risks for long COVID
On May 11, 2023, a National Institutes of Health supported long-term study reported that among people who have…
U.S. Department of Health and Human Services ended the COVID-19 Public Health Emergency
On May 11, 2023, the U.S. Departments of Health and Human Services announced an end of the COVID-19…
World Health Organization ended its declaration of COVID-19 as a global health emergency
On May 5, 2023, the World Health Organization (WHO) ended its declaration of COVID-19 as a global health…
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
U.S. FDA issued Emergency Use Authorization for new COVID-19 Over-the-Counter at-home antigen test
On Apr. 24, 2023, the U.S. FDA authorized Status COVID-19 Antigen Rapid Test for Home Use (manufactured by…
LU.S. state-by-state analysis of COVID-19 impact revealed driving forces behind variations in health published in The Lancet
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
U.S. FDA issued EUA for new COVID-19 over-the-counter at-home antigen test
On Apr. 14, 2023, the U.S. FDA issued an emergency use authorization for the Azure Fastep COVID-19 Antigen…
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, NIH-funded research was announced from the University of Rochester and Harvard University that looked…
Antibiotics do not cut death risk in hospitalized patients with viral respiratory illnesses
On Mar. 24. 2023, antibiotics do not reduce the risk of dying in adults hospitalized with COVID-19, the…
Tuberculosis in the U.S. increased slightly during 2022 although it remained lower than prepandemic years
On Mar. 24, 2023, the CDC announced that Tuberculosis in the U.S. increased slightly during 2022 although it…
Paxlovid reduced risk of long-term health problems, death from COVID-19
On Mar. 23. 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
Quest Diagnostics announced first-of-its-kind post-COVID-19 panels available
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
Biotechnology | COVID-19 | NIH | Pharmaceutical | Vaccine
SARS-CoV-2 infection weakens immune-cell response to vaccination
On Mar. 20, 2023, NIH scientists announced that the magnitude and quality of a key immune cellï¾’s response…
FDA Advisory Committee voted in support of favorable benefit-risk profile for Pfizerï¾’s PAXLOVIDï¾™
On Mar. 16, 2023, Pfizer announced that the U.S. Food and Drug Administrationï¾’s Antimicrobial Drugs Advisory Committee voted…
FDA authorized bivalent Pfizer-BioNTech COVID-19 vaccine as booster dose for certain children 6 months through 4 years of age
On Mar. 14, 2023, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the…
‘Deaths of Despair’ contributed to 17% rise in Minnesota’s death rate during COVID-19 pandemic
On Mar. 13, 2023, Mayo Clinic published a study that showed the COVID-19 pandemic was linked to a…
QuidelOrtho received de novo FDA authorization for Sofia 2 SARS Antigen+ FIA
On Mar. 8, 2023, QuidelOrtho announced that it had been granted a De Novo request from the U.S….
In a first for imaging, new microscope captured details, 3D motion of molecules in liquid
On Mar. 7, 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
Pfizer and BioNTech submitted for U.S. EUA of Omicron BA.4/BA.5-adapted bivalent COVID-19 booster in children under 5 years
On Mar. 1, 2023, BioNTech and Pfizer announced that they had submitted an application to the U.S. Food…
FDA authorized first OTC at-home test to detect both influenza and COVID-19 viruses
On Feb. 24, 2023, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the…
Moderna to make milestone payments to NIH for COVID vaccine
On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…
Vekluryï¾® (Remdesivir) reduced risk of mortality in hospitalized COVID-19 patients across all variants in real world study
On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
Higher-Dose and longer duration of Ivermectin not effective with COVID-19
On Feb. 20, 2023, results from a randomized clinical trial of Ivermectin in a higher-hose and longer duration…
Health Canada authorizeds Moderna’s Omicron-targeting bivalent COVID-19 vaccine in children & cdolescents
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…